InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,127.79
(
1.26%
)
US TECH 100
17,446.00
(
2.17%
)
Dow Jones
38,675.68
(
1.18%
)
Brent Oil
82.77
(
0.00%
)
Bitcoin
64,081.47
(
1.90%
)

Replies to post #6061 on AVANIR PHARMACEUTICALS (AVNR)

Replies to #6061 on AVANIR PHARMACEUTICALS (AVNR)

Prudent Capitalist

07/28/14 5:21 PM

#6062 RE: sts66 #6061

Nuedexta is a one and only commercially marketed formulation, and with the patents just being upheld, there will be no competing drug and no generics until late 2026.